MDXG Q1 2017 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$73M+36.1% YoY

Gross Profit

$64M88.0% margin

Operating Income

$6M8.5% margin

Net Income

$4M6.0% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+3.9%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$10M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$188M

Total Liabilities

$59M

Stockholders' Equity

$129M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$73M	$53M	+36.1%
Gross Profit	$64M	$45M	+40.6%
Operating Income	$6M	$1M	+321.6%
Net Income	$4M	$1M	+261.5%